| Financial Year |
March 31 2023 |
| Monetary Funds |
149,012,897.78 |
| Held-for-trading Financial Assets |
20,000,000.00 |
| Notes Receivable |
278,611,465.22 |
| Accounts Receivable |
281,534,419.86 |
| Advances to Suppliers |
12,346,534.04 |
| Other Receivables |
2,142,400.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
254,284,901.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
110,575.86 |
| Total Current Assets |
998,043,194.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
260,698,251.91 |
| Under-construction Projects |
74,365,636.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
24,114,544.98 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,374,101.77 |
| Deferred Income Tax Assets |
7,424,577.33 |
| Other Non-Current Assets |
37,409,384.35 |
| Sub-Total of Non-Current Assets |
407,172,045.73 |
| Total Assets |
1,405,215,240.72 |
| Short-Term Loans |
20,704,629.46 |
| Trading Financial liabilities |
-- |
| Notes Payable |
246,661,584.27 |
| Accounts Payable |
167,964,032.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
34,701,178.54 |
| Taxes Payable |
11,157,815.46 |
| Interest Payable |
72,248.49 |
| Dividend Payable |
-- |
| Other payables |
485,945.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,621,182.53 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
493,221,176.82 |
| Long-term Loans |
39,777,644.09 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
170,266.12 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
42,078,343.97 |
| Total Liabilities |
535,299,520.79 |
| Paid-In Capital(Or Share Stock) |
66,277,427.00 |
| Capital Surplus |
465,738,226.28 |
| Surplus Reserve |
33,138,713.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
304,761,353.15 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
869,915,719.93 |
| Owner's Equity（Stockholder's Equity） |
869,915,719.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,405,215,240.72 |
